EUCTR2012-001155-39-Outside-EU/EEA进行中（未招募）不适用
Phase I trial of AZD2171, an orally bioavailable antiangiogenic agent, in children and adolescents with refactory or recurrent solid tumours or acute myelogenous leukemia
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients must be greater than 2 and less than 19 years of age
- •Solid tumours: histologically confirmed extracranial malignant solid tumours
- •Leukemia : histologically confirmed acute AML
- •Patients cancer must have relapsed after or failed to respond to frontline standard therapy and no other standard curative treatment options are available
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with primary brain tumours, active CNS metastasis, or active spinal cord metastasis or compression. AML patients with CNS leukemia.
- •Patients receiving medication for treatment of hypertension or patients with a diastolic blood pressure 5mmHg greater than the 95% for gender and age on 3 measurements
研究者
相似试验
进行中（未招募）
1 期
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With DyslipidemiaCardiovascularNCT06238466AstraZeneca98
已完成
1 期
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese SubjectsChronic Obstructive Pulmonary Disease - COPDNCT03159442AstraZeneca25
已完成
1 期
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseNCT02814656AstraZeneca24
已完成
2 期
AZD2171 in Treating Patients With Recurrent or Stage IV MelanomaAcral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension MelanomaIntraocular MelanomaLentigo Maligna Malignant MelanomaRecurrent MelanomaStage, Intraocular MelanomaStage IV MelanomaSuperficial Spreading Malignant MelanomaIris MelanomaNCT00243061National Cancer Institute (NCI)24
已完成
1 期
A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.Healthy VolunteersNCT04269031AstraZeneca30